NCT03296371View on ClinicalTrials.gov

Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdomyosarcoma

Active, not recruitingOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

October 23, 2017

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2025

Conditions
Alveolar RhabdomyosarcomaEmbryonal Rhabdomyosarcoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo saliva or buccal mucosa collection

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

19104

Childrens Oncology Group, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK